Article Versions Notes

Dardari D, Thomas C, Laborne F-X, Tourte C, Henry E, Erblang M, Bourdon S, Penfornis A, Lopes P. Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study. Medicina. 2022; 58(4):555. https://doi.org/10.3390/medicina58040555

Dardari, Dured, Claire Thomas, Francois-Xavier Laborne, Caroline Tourte, Elodie Henry, Megane Erblang, Stéphanie Bourdon, Alfred Penfornis, and Philippe Lopes. 2022. "Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study" Medicina 58, no. 4: 555. https://doi.org/10.3390/medicina58040555

Dardari, D., Thomas, C., Laborne, F.-X., Tourte, C., Henry, E., Erblang, M., Bourdon, S., Penfornis, A., & Lopes, P. (2022). Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study. Medicina, 58(4), 555. https://doi.org/10.3390/medicina58040555